アダムがエフに出会う:ADAMの基板認識モジュールは,トランスにおけるエフリン分裂のための分子スイッチとして機能する
Peter W Janes1, Nayanendu Saha, William A Barton
1Department of Biochemistry and Molecular Biology, PO Box 13D, Monash University, Victoria 3800, Australia.
Cell
|October 22, 2005
まとめ
ADAM10 (メタルプロテアゼ) は,EphA3受容体に結合するエフリン-A5リガンドを裂き,細胞の排斥を媒介する. 反対の細胞の間に発生するこのプロセスは,結合されたエフリンだけが割れ目の標的であることを保証します.
科学分野:
- 細胞生物学 細胞生物学
- 細胞同士のコミュニケーションの分子メカニズム
- 信号伝達におけるプロテアゼの機能
背景:
- エフ受容体チロシンキナーゼとエフリンリンガンドは細胞間の通信を媒介する.
- ADAM10メタロプロテアゼはエフリン-A2を分裂させ,細胞の排斥を引き起こします.
- エフリンとのADAM10相互作用の調節は完全に理解されていません.
研究 の 目的:
- エフ結合エフリンをADAM10が選択的に割るメカニズムを解明する.
- ADAM10-エフリン相互作用の構造的,機能的基礎を定義する.
- ADAM10媒介のエフリンタンパク質分解の調節を理解するために.
主な方法:
- ADAM10ドメインの構造分析.
- EphA3/エフリン-A5複合体を用いた機能的研究.
- タンパク質とタンパク質の相互作用と分裂現象を調査する.
主要な成果:
- ADAM10は,特定の基質認識モジュールを介してEphA3/エフリン-A5複合体を認識します.
- 機能的複合体の形成は,ADAM10.の認識モチーフを作成します.
- ADAM10によるエフリン-A5の割れは,対極の細胞間のトランスで起こります.
結論:
- ADAM10は,その分解とシステインに富んだドメインを含む基板認識モジュールを使用しています.
- EphA3とエフリン-A5の間の複合体の形成は,ADAM10の結合と分裂に不可欠です.
- トランス作用メカニズムはADAM10媒介のエフリンタンパク質分解を調節し,特異性を確保します.
関連する概念動画
Enzyme Inhibition
72.4K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
72.4K
Olefin Metathesis Polymerization: Acyclic Diene Metathesis (ADMET)
1.4K
Acyclic diene metathesis polymerization or ADMET polymerization involves cross-metathesis of terminal dienes, such as 1,8-nonadiene, to give linear unsaturated polymer and ethylene. As ADMET is a reversible process, the formed ethylene gas must be removed from the reaction mixture to complete the polymerization process.
Similar to cross-metathesis, ADMET also involves the formation of metallacyclobutane intermediate by [2+2] cycloaddition of one of the double bonds of a terminal diene with...
Similar to cross-metathesis, ADMET also involves the formation of metallacyclobutane intermediate by [2+2] cycloaddition of one of the double bonds of a terminal diene with...
1.4K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
1.8K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
1.8K
Adrenergic Receptors: ɑ Subtype
2.7K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.7K
Adrenergic Agonists: Mixed-Action Agents
1.7K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.7K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.9K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.9K


